<DOC>
	<DOC>NCT02419352</DOC>
	<brief_summary>Post operative cognitive dysfunction (POCD) is recognized as a frequent complication after both cardiac and non cardiac surgery, affecting approximately 1/3 of the patients. The aim of this study is to examine the possible effect of the novel reversal agent sugammadex versus neostigmine/ atropine combination on cognitive function of adult patients after elective surgery during the early post operative period as well as at discharge.</brief_summary>
	<brief_title>Sugammadex and Cognitive Function</brief_title>
	<detailed_description />
	<mesh_term>Atropine</mesh_term>
	<mesh_term>Neostigmine</mesh_term>
	<criteria>Patients aged &gt;40 years old ASA IIII Patients scheduled for elective surgery with general anaesthesia. Neuro, vascular, orthopedic or cardiac surgery Known psychiatric or disease of the CNS History of craniotomy Receiving tranquillisers or antidepressants on a regular basis preoperatively Alcoholism or drug dependence History of stroke Refusal of patient Inability to read or write MMSE &lt; 22 preoperatively</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Cognitive function</keyword>
</DOC>